RGCRegencell Bioscience Holdings Limited

$5.53

Who owns RGC

30 institutions reported holding RGC for 2026Q1, together 0.13% of the company, more than the 16 a quarter earlier.

30

Institutions reporting a position · as of 2026Q1 · up from 16 the quarter before

Shares held by institutions
0.6M

Shares held by institutions · 0.13% of the company · long US equity positions only, as reported on Form 13F

Reported value
$16M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
0.11%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
19
New positions
18
Positions exited
4
Added to
6
Reduced
4
Top 10 holdersof the company
0.13%
Institutional ownership by quarter, 2021Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q1300.6M$16M
2025Q4160.5M$12M
2025Q3160.6M$9.8M
2025Q2140.7M$12M
2025Q150.0M$281K
2024Q430.0M$156K
2024Q320.0M$100K
2024Q230.0M$2K
2024Q130.0M$7K
2023Q430.0M$171K
2023Q340.0M$9K
2023Q220.0M$12K
2023Q140.0M$19K
2022Q430.0M$32K
2022Q350.0M$260K
2022Q250.0M$296K
Largest reported holders, 2026Q1
HolderShares% of companyValue
GEODE CAPITAL MANAGEMENT LLC0.4M0.08%$11M
Marex Group plc0.0M0.01%$804K
GSA CAPITAL PARTNERS LLP0.0M0.01%$803K
Vident Advisory, LLC0.0M0.01%$752K
Squarepoint Capital LLP0.0M0.01%$677K
UBS Group AG0.0M0.01%$607K
MORGAN STANLEY0.0M0.00%$511K
BANK OF AMERICA CORP /DE/0.0M0.00%$437K
STATE STREET CORP0.0M0.00%$301K
Legal & General Group Plc0.0M0.00%$252K

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…